AtriCure, Inc. (ATRC)
$48.54-$0.73 (-1.48%) Today
Sven Wehrwein - DirectorAtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 6 | 53,616 | $2.15M |
| Grant or award | 5 | 3,071 | |
| Option exercise | 2 | 50,000 | |
| Bona-fide gift | 2 | 4,700 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
50 Form 4 filings on record, the earliest from Dec 12, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Douglas J. Seith - Officer | Grant or award | Common Stock | 42,386 | $0.00 | - | |
| Douglas J. Seith - Officer | Grant or award | Common Stock | 25,532 | $0.00 | - | |
| Douglas J. Seith - Officer | Tax withholding / forfeiture | Common Stock | 22,948 | $31.26 | $717K | |
| Karl S. Dahlquist - Officer | Grant or award | Common Stock | 15,198 | $0.00 | - | |
| Karl S. Dahlquist - Officer | Tax withholding / forfeiture | Common Stock | 15,687 | $31.26 | $490K | |
| Karl S. Dahlquist - Officer | Grant or award | Common Stock | 27,991 | $0.00 | - | |
| Justin J. Noznesky - Officer | Open-market sale | Common Stock | 5,166 | $37.29 | $193K | |
| Sven Wehrwein - Director | Option exercise | Common Stock | 5,033 | $19.95 | $100K | |
| Sven Wehrwein - Director | Option exercise | Common Stock | 4,967 | $19.95 | $99K | |
| Sven Wehrwein - Director | Open-market sale | Common Stock | 4,967 | $38.00 | $189K | |
| Sven Wehrwein - Director | Open-market sale | Common Stock | 5,033 | $37.32 | $188K | |
| Sven Wehrwein - Director | Option exercise | Non-qualified Stock Option (right to buy) | 5,033 | $0.00 | - | |
| Sven Wehrwein - Director | Option exercise | Non-qualified Stock Option (right to buy) | 4,967 | $0.00 | - | |
| Maggie Yuen - Director | Open-market sale | Common Stock | 3,000 | $35.72 | $107K | |
 Michael H. Carrel - Officer | Gift | Common Stock | 6,000 | $0.00 | - | |
| Justin J. Noznesky - Officer | Open-market sale | Common Stock | 3,000 | $36.30 | $109K | |
| Sven Wehrwein - Director | Option exercise | Common Stock | 5,000 | $19.95 | $100K | |
| Sven Wehrwein - Director | Open-market sale | Common Stock | 5,000 | $37.00 | $185K | |
| Sven Wehrwein - Director | Option exercise | Non-qualified Stock Option (right to buy) | 5,000 | $0.00 | - | |
| Sven Wehrwein - Director | Option exercise | Common Stock | 5,000 | $19.95 | $100K | |
| Sven Wehrwein - Director | Open-market sale | Common Stock | 5,000 | $36.00 | $180K | |
| Sven Wehrwein - Director | Option exercise | Non-qualified Stock Option (right to buy) | 5,000 | $0.00 | - | |
| Michael H. Carrel - Officer | Gift | Common Stock | 10,000 | $0.00 | - | |
 Regina E. Groves - Director | Open-market sale | Common Stock | 2,452 | $36.82 | $90K | |
| Vinayak Doraiswamy - Officer | Open-market sale | Common Stock | 2,500 | $36.58 | $91K | |
 Salvatore Privitera - Officer | Grant or award | Common Stock | 822 | $25.84 | $21K | |
| Douglas J. Seith - Officer | Grant or award | Common Stock | 550 | $25.84 | $14K | |
| Karl S. Dahlquist - Officer | Grant or award | Common Stock | 822 | $25.84 | $21K | |
| Vinayak Doraiswamy - Officer | Grant or award | Common Stock | 822 | $25.84 | $21K | |
| Michael H. Carrel - Officer | Grant or award | Common Stock | 822 | $25.84 | $21K | |
| Sven Wehrwein - Director | Grant or award | Common Stock | 5,401 | $0.00 | - | |
| B. Kristine Johnson - Director | Grant or award | Common Stock | 5,401 | $0.00 | - | |
| Justin J. Noznesky - Officer | Gift | Common Stock | 585 | $0.00 | - |
This is as far as the anonymous view goes. Create a free account for all 50 ATRC filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| KARL DAHLQUIST | Officer | 9,370 | $458K | View on EDGAR | |
| Prange Karen | Director | 3,564 | $139K | View on EDGAR | |
| MAGGIE YUEN | Director | 3,500 | $134K | View on EDGAR |
AtriCure, Inc. (ATRC) had 12 insider filings in the last 90 days, with the most recent on 2026-08-26. The full record for ATRC runs to 50 Form 4 filings, the earliest from 2024-12-12. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of ATRC were filed in the last 90 days.
6 insider sales of ATRC were filed in the last 90 days, totaling $2.15M.
This page tracks ATRC Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add ATRC to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
